跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
張 毓成
主治醫師
,
臺北市立萬芳醫院
電子郵件
108004
w.tmu.edu
tw
h-index
46
引文
4
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2022
2025
每年研究成果
概覽
指紋
網路
研究成果
(5)
類似的個人檔案
(8)
指紋
查看啟用 Yu-Cheng Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
11%
Allergic Asthma
50%
Allergic Disease
10%
Allergy
10%
anthra[1,9 Cd]pyrazol 6(2h) One
10%
Antiallergic Drug
50%
Antiinflammatory Activity
10%
Capecitabine
23%
Chemotherapy Regimens
100%
Colorectal Carcinoma
50%
Combination Therapy
7%
Cytokine
10%
Dysbiosis
13%
Eosinophilia
10%
Fluorouracil
11%
Histamine
10%
Immune Checkpoint Inhibitor
50%
Immunoglobulin E
50%
Interleukin 13
20%
Interleukin 4
20%
Interleukin 5
10%
Interleukin 6
20%
Isoquinoline Alkaloid
10%
Liver Cell Carcinoma
13%
Lung Disease
10%
Melanoma
13%
Non Small Cell Lung Cancer
13%
Oral Administration
10%
Ovalbumin
50%
Overall Survival
17%
Phosphotransferase
10%
Phosphotransferase Inhibitor
10%
Progression Free Survival
17%
Prostaglandin D2
20%
Proton Pump Inhibitor
100%
Random Effects Model
8%
Receptor
10%
Renal Cell Carcinoma
13%
Respiratory Tract Allergy
10%
Respiratory Tract Inflammation
10%
Squamous Cell Carcinoma
13%
Transitional Cell Carcinoma
13%
Tumor Necrosis Factor
10%
Immunology and Microbiology
Airway
10%
Allergic Asthma
50%
Allergic Disease
10%
Allergy
10%
Amino Terminal Sequence
20%
Antiinflammatory Activity
10%
Body Weight
10%
Bone Marrow Derived Mast Cell
20%
Bronchoalveolar Lavage Fluid
20%
CD4
10%
Cell Activation
50%
Degranulation
20%
Histamine
10%
Immunoglobulin E
50%
Inflammation
10%
Inflammatory Cell
10%
Inflammatory Cytokine
10%
Interleukin 13
20%
Interleukin 4
20%
Interleukin 5
10%
Interleukin 6
20%
Kinase
20%
Lung
10%
Mast Cell
50%
Mediator
10%
Phosphotransferase
20%
Prostaglandin D2
20%
Receptor Affinity
10%
Respiratory Tract Allergy
10%
Signal Transduction
10%
T Cell
10%
Tumor Necrosis Factor
10%
Nursing and Health Professions
All Cause Mortality
11%
Capecitabine
23%
Chemotherapy
50%
Colorectal Carcinoma
50%
Combination Therapy
7%
Fluorouracil
11%
Medline
7%
Proton Pump Inhibitor
50%
Systematic Review with Meta-Analysis
50%
